Cargando…
Cyclic RGD-Decorated Liposomal Gossypol AT-101 Targeting for Enhanced Antitumor Effect
INTRODUCTION: (-)-Gossypol (AT-101), the (-)-enantiomer of the natural compound gossypol, has shown significant inhibitory effects on various types of cancers such as osteosarcoma, myeloma, glioma, lung cancer, and prostate cancer. However, the clinical application of (-)-gossypol was often hindered...
Autores principales: | Liu, Hao, Zhang, Ruirui, Zhang, Dan, Zhang, Chun, Zhang, Zhuo, Fu, Xiujuan, Luo, Yu, Chen, Siwei, Wu, Ailing, Zeng, Weiling, Qu, Kunyan, Zhang, Hao, Wang, Sijiao, Shi, Houyin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766252/ https://www.ncbi.nlm.nih.gov/pubmed/35068931 http://dx.doi.org/10.2147/IJN.S341824 |
Ejemplares similares
-
Gastric floating tablet improves the bioavailability and reduces the hypokalemia effect of gossypol in vivo
por: Liu, Hao, et al.
Publicado: (2021) -
Urokinase-loaded cyclic RGD-decorated liposome targeted therapy for in-situ thrombus of pulmonary arteriole of pulmonary hypertension
por: Li, Jingtao, et al.
Publicado: (2022) -
Systematic Review of Gossypol/AT-101 in Cancer Clinical Trials
por: Renner, Olga, et al.
Publicado: (2022) -
Strategic developments in the drug delivery of natural product dihydromyricetin: applications, prospects, and challenges
por: Zhang, Ruirui, et al.
Publicado: (2022) -
Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid–paclitaxel (CLA-PTX) on B16-F10 melanoma
por: Du, Ruo, et al.
Publicado: (2014)